Laura Carreras-Planella
Overview
Explore the profile of Laura Carreras-Planella including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
520
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Garcia S, Sandoval-Hellin N, Clos-Sansalvador M, Carreras-Planella L, Moron-Font M, Guerrero D, et al.
Front Immunol
. 2022 Oct;
13:957797.
PMID: 36189264
Regulatory B cells (Breg) are essential players in tolerance and immune homeostasis. However, lack of specific Breg markers limit their potential in clinical settings. Mesenchymal stromal cells (MSC) modulate B...
2.
Carreras-Planella L, Cucchiari D, Canas L, Juega J, Franquesa M, Bonet J, et al.
J Nephrol
. 2020 Dec;
34(3):861-874.
PMID: 33275196
Background: In kidney transplantation, fibrosis represents the final and irreversible consequence of the pathogenic mechanisms that lead to graft failure, and in the late stages it irremediably precedes the loss...
3.
Carreras-Planella L, Juega J, Taco O, Canas L, Franquesa M, Lauzurica R, et al.
Int J Mol Sci
. 2020 Oct;
21(20).
PMID: 33066346
Use of immunosuppressive drugs is still unavoidable in kidney-transplanted patients. Since their discovery, calcineurin inhibitors (CNI) have been considered the first-line immunosuppressive agents, in spite of their known nephrotoxicity. Chronic...
4.
Bonomini M, Borras F, Troya-Saborido M, Carreras-Planella L, Di Liberato L, Arduini A
Int J Mol Sci
. 2020 Aug;
21(15).
PMID: 32752018
Peritoneal dialysis (PD) is an established home care, cost-effective renal replacement therapy (RRT), which offers several advantages over the most used dialysis modality, hemodialysis. Despite its potential benefits, however, PD...
5.
Carreras-Planella L, Monguio-Tortajada M, Borras F, Franquesa M
Front Immunol
. 2019 Oct;
10:2413.
PMID: 31660058
[This corrects the article DOI: 10.3389/fimmu.2019.01288.].
6.
Carreras-Planella L, Soler-Majoral J, Rubio-Esteve C, Moron-Font M, Franquesa M, Bonal J, et al.
J Nephrol
. 2019 Oct;
32(6):1021-1031.
PMID: 31617158
Background: Peritoneal dialysis (PD) is an optimal renal replacement therapy for patients while waiting for kidney transplantation, but functional failure of the peritoneal membrane (PM), mainly induced by exposure to...
7.
Carreras-Planella L, Monguio-Tortajada M, Borras F, Franquesa M
Front Immunol
. 2019 Jun;
10:1288.
PMID: 31244839
Mesenchymal stem or stromal cells (MSC) have proven immunomodulatory properties toward B cell activation and induce regulatory B cells (Breg), through a dual mechanism of action that relies both on...
8.
Monguio-Tortajada M, Moron-Font M, Gamez-Valero A, Carreras-Planella L, Borras F, Franquesa M
Curr Protoc Stem Cell Biol
. 2019 Jan;
49(1):e82.
PMID: 30698351
This unit describes how to isolate extracellular vesicles (EVs) from different biological fluids using size-exclusion chromatography (SEC) and how to prepare your starting sample and the EV product for downstream...
9.
Lozano-Ramos S, Bancu I, Carreras-Planella L, Monguio-Tortajada M, Canas L, Juega J, et al.
BMC Nephrol
. 2018 Aug;
19(1):189.
PMID: 30064375
Background: Kidney transplantation (KTx) is the best therapeutic approach for chronic kidney diseases leading to irreversible kidney failure. Considering the origin of the graft, several studies have reported differences between...
10.
Luk F, Carreras-Planella L, Korevaar S, De Witte S, Borras F, Betjes M, et al.
Front Immunol
. 2017 Sep;
8:1042.
PMID: 28894451
The immunomodulatory capacity of mesenchymal stem or stromal cells (MSC) makes them a promising tool for treatment of immune disease and organ transplantation. The effects of MSC on B cells...